About TruTechnologies

About TruTechnologies — A friendship that became a mission

Bring truth to every trial.

Technology built for the realities of modern clinical research — so therapies reach patients sooner.

OUR STORY

TruTechnologies began with a partnership between two longtime friends who had each spent their careers watching the same problem play out from opposite sides of regulated industries.

Dr. Richard Graham (Rick) spent more than 25 years inside drug development as a clinical pharmacologist and biopharma executive. He had seen, again and again, how fragile manual processes at clinical sites could compromise even the strongest science: late-arriving sample data;  paper trails;  switched specimens; and FDA questions that surfaced years after a patient had given their time, blood and hope. For years he pressed the industry to act. People agreed the problem was real. Nothing meaningful changed.

That is, until a family get-together in late 2018, when Rick brought the problem to Scott Ogle. As President and CEO of Sageworks, Scott had spent his career replacing paper and fragmented workflows with software in another tightly regulated field: financial services. The mission was also personal: As a teenager, he watched his father endure a six-year battle with a rare cancer, giving him a firsthand understanding of how deeply families are impacted when new therapies are still out of reach.

Rick knew the problem from the inside. Scott knew how to build software that could solve it. Together, they founded TruTechnologies to bring truth to every trial.

Inside a clinical research site where TruTechnologies operates
WHERE THE WORK BEGAN
OUR TIMELINE

From a sample-tracking idea to a category-defining platform.

A short history of how TruTechnologies grew from a focused fix for clinical sample integrity into a platform that helps sponsors see what is happening in a trial while there is still time to act.

  1. / 01
    2018

    Founded to solve sample tracking.

    Initial market research revealed a staggering problem: nearly 20% of clinical trial samples are unusable due to preventable errors. TruTechnologies was founded to fix it at the source.

  2. / 02
    2021

    12 sponsors running TruLab in global trials.

    Implementation at scale taught us that tracking samples is ultimately about protocol compliance: understanding whether trial activities are happening as intended, while there's still time to act.

  3. / 03
    2024

    Deployed in 1,000+ clinical sites.

    TruLab's ability to simplify operations and offer live, on-the-go support drives exceptional site adoption across global trials.

  4. / 04
    2025

    TruLab becomes TruTechnologies.

    The rebrand reflects our evolution from a single product into a broader platform for live  visibility into clinical trial execution.

  5. / 05
    2025
    / Milestone investment

    LLR Partners invests in TruTechnologies.

    Growth investment from LLR Partners accelerates our roadmap, expands the team, and deepens the platform — fuel for a category we created and now lead.

  6. / 06
    2026

    Reached 3,300+ sites and 60 countries.

    TruTechnologies now supports clinical research across every trial phase and therapeutic area worldwide.

  7. / 07
    2026

    New Tru brand identity and further product innovation.

    A refreshed visual identity reflects Tru’s growth and momentum as the platform continues to evolve.

Founders

Built by drug development and technology leaders.